The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Trastuzumab Injection Market Research Report 2024
Synopsis
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
Global Trastuzumab Injection market is projected to reach US$ 1098.8 million in 2029, increasing from US$ 775 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Trastuzumab Injection market research.
Key manufacturers engaged in the Trastuzumab Injection industry include Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca and Remegen Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Trastuzumab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Trastuzumab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Trastuzumab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Roche
Celltrion
Amgen
Samsung Bioepsis
Mylan
Glenmark
AstraZeneca
Remegen Co., Ltd.
Hisun Biopharmaceutical
Shanghai Henlius Biotech
Segment by Type
60 mg
150 mg
440 mg
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Trastuzumab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
Global Trastuzumab Injection market is projected to reach US$ 1098.8 million in 2029, increasing from US$ 775 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Trastuzumab Injection market research.
Key manufacturers engaged in the Trastuzumab Injection industry include Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca and Remegen Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Trastuzumab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Trastuzumab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Trastuzumab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Roche
Celltrion
Amgen
Samsung Bioepsis
Mylan
Glenmark
AstraZeneca
Remegen Co., Ltd.
Hisun Biopharmaceutical
Shanghai Henlius Biotech
Segment by Type
60 mg
150 mg
440 mg
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Trastuzumab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Trastuzumab Injection Market Overview
1.1 Product Overview and Scope of Trastuzumab Injection
1.2 Trastuzumab Injection Segment by Type
1.2.1 Global Trastuzumab Injection Market Value Comparison by Type (2023-2029)
1.2.2 60 mg
1.2.3 150 mg
1.2.4 440 mg
1.2.5 Others
1.3 Trastuzumab Injection Segment by Application
1.3.1 Global Trastuzumab Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Trastuzumab Injection Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Injection Revenue 2018-2029
1.4.2 Global Trastuzumab Injection Sales 2018-2029
1.4.3 Global Trastuzumab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Trastuzumab Injection Market Competition by Manufacturers
2.1 Global Trastuzumab Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Trastuzumab Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Trastuzumab Injection Average Price by Manufacturers (2018-2023)
2.4 Global Trastuzumab Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Trastuzumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trastuzumab Injection, Product Type & Application
2.7 Trastuzumab Injection Market Competitive Situation and Trends
2.7.1 Trastuzumab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Trastuzumab Injection Players Market Share by Revenue
2.7.3 Global Trastuzumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Trastuzumab Injection Retrospective Market Scenario by Region
3.1 Global Trastuzumab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Trastuzumab Injection Global Trastuzumab Injection Sales by Region: 2018-2029
3.2.1 Global Trastuzumab Injection Sales by Region: 2018-2023
3.2.2 Global Trastuzumab Injection Sales by Region: 2024-2029
3.3 Global Trastuzumab Injection Global Trastuzumab Injection Revenue by Region: 2018-2029
3.3.1 Global Trastuzumab Injection Revenue by Region: 2018-2023
3.3.2 Global Trastuzumab Injection Revenue by Region: 2024-2029
3.4 North America Trastuzumab Injection Market Facts & Figures by Country
3.4.1 North America Trastuzumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Trastuzumab Injection Sales by Country (2018-2029)
3.4.3 North America Trastuzumab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trastuzumab Injection Market Facts & Figures by Country
3.5.1 Europe Trastuzumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Trastuzumab Injection Sales by Country (2018-2029)
3.5.3 Europe Trastuzumab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trastuzumab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Trastuzumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Trastuzumab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Trastuzumab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Trastuzumab Injection Market Facts & Figures by Country
3.7.1 Latin America Trastuzumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Trastuzumab Injection Sales by Country (2018-2029)
3.7.3 Latin America Trastuzumab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trastuzumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Trastuzumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Trastuzumab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Trastuzumab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trastuzumab Injection Sales by Type (2018-2029)
4.1.1 Global Trastuzumab Injection Sales by Type (2018-2023)
4.1.2 Global Trastuzumab Injection Sales by Type (2024-2029)
4.1.3 Global Trastuzumab Injection Sales Market Share by Type (2018-2029)
4.2 Global Trastuzumab Injection Revenue by Type (2018-2029)
4.2.1 Global Trastuzumab Injection Revenue by Type (2018-2023)
4.2.2 Global Trastuzumab Injection Revenue by Type (2024-2029)
4.2.3 Global Trastuzumab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Trastuzumab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Trastuzumab Injection Sales by Application (2018-2029)
5.1.1 Global Trastuzumab Injection Sales by Application (2018-2023)
5.1.2 Global Trastuzumab Injection Sales by Application (2024-2029)
5.1.3 Global Trastuzumab Injection Sales Market Share by Application (2018-2029)
5.2 Global Trastuzumab Injection Revenue by Application (2018-2029)
5.2.1 Global Trastuzumab Injection Revenue by Application (2018-2023)
5.2.2 Global Trastuzumab Injection Revenue by Application (2024-2029)
5.2.3 Global Trastuzumab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Trastuzumab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Trastuzumab Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche Trastuzumab Injection Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Celltrion
6.3.1 Celltrion Corporation Information
6.3.2 Celltrion Description and Business Overview
6.3.3 Celltrion Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Celltrion Trastuzumab Injection Product Portfolio
6.3.5 Celltrion Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amgen Trastuzumab Injection Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Samsung Bioepsis
6.5.1 Samsung Bioepsis Corporation Information
6.5.2 Samsung Bioepsis Description and Business Overview
6.5.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Samsung Bioepsis Trastuzumab Injection Product Portfolio
6.5.5 Samsung Bioepsis Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mylan Trastuzumab Injection Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Glenmark
6.6.1 Glenmark Corporation Information
6.6.2 Glenmark Description and Business Overview
6.6.3 Glenmark Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Glenmark Trastuzumab Injection Product Portfolio
6.7.5 Glenmark Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Trastuzumab Injection Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Remegen Co., Ltd.
6.9.1 Remegen Co., Ltd. Corporation Information
6.9.2 Remegen Co., Ltd. Description and Business Overview
6.9.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Remegen Co., Ltd. Trastuzumab Injection Product Portfolio
6.9.5 Remegen Co., Ltd. Recent Developments/Updates
6.10 Hisun Biopharmaceutical
6.10.1 Hisun Biopharmaceutical Corporation Information
6.10.2 Hisun Biopharmaceutical Description and Business Overview
6.10.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolio
6.10.5 Hisun Biopharmaceutical Recent Developments/Updates
6.11 Shanghai Henlius Biotech
6.11.1 Shanghai Henlius Biotech Corporation Information
6.11.2 Shanghai Henlius Biotech Trastuzumab Injection Description and Business Overview
6.11.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolio
6.11.5 Shanghai Henlius Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trastuzumab Injection Industry Chain Analysis
7.2 Trastuzumab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trastuzumab Injection Production Mode & Process
7.4 Trastuzumab Injection Sales and Marketing
7.4.1 Trastuzumab Injection Sales Channels
7.4.2 Trastuzumab Injection Distributors
7.5 Trastuzumab Injection Customers
8 Trastuzumab Injection Market Dynamics
8.1 Trastuzumab Injection Industry Trends
8.2 Trastuzumab Injection Market Drivers
8.3 Trastuzumab Injection Market Challenges
8.4 Trastuzumab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
